HLA-A and viral infectious disease: In the current study, we designed the HTNV linear multi-epitope peptide consisting of HLA-A*02-restricted HTNV CTL epitope and PADRE, and evaluated the multi-epitope peptide as candidate vaccine in HLA-A2.1/Kb Tg mice as a virus infection model of immunizing the Tg mice following HTNV challenge.